Clinical trial
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
NCT00443430 · Seattle Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00443430 |
|---|---|
| Title | Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis |
| Official title | Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis (TREAT in JIA) |
| Lead sponsor | Seattle Children's Hospital, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Amgen Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Juvenile Chronic Polyarthritis, Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | methotrexate, methotrexate - etanercept - prednisolone arm |
| Enrollment | 85 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Mar 6, 2007 |
| Last update posted | May 31, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: